Assertion: fluoxetine | /r/HasProperty | 20 mg
Facets:
value: /day
type: TEMPORAL
Source sentences:
text: In a multicentre randomised double blind continuation of those who were in remission after 12 weeks of open label fluoxetine 20 mg/day, after 50 weeks (total duration) of fluoxetine 20 mg/day, the fluoxetine treated patients had a statistically significantly lower rate of re-emergence of depressive symptoms than those on placebo.
text: These patients were randomized to double-blind, once-weekly continuation treatment with fluoxetine delayed-release capsules 90 mg once weekly, PROZAC 20 mg once daily, or placebo.
text: The average DRSP total score decreased by 38% on fluoxetine 20 mg/day, 35% on fluoxetine 10 mg/day and 30% on placebo.
text: The average DRSP social and functional impairment symptom cluster score decreased 42% on fluoxetine 20 mg/day, 40% on fluoxetine 10 mg/day and 33% on placebo.
text: Fluoxetine 20 mg and 60 mg per day were also significantly more effective than placebo on a number of secondary measures of mood, physical symptoms and social impairment.
text: In a multicentre randomised double blind continuation of those who were in remission after 12 weeks of open label fluoxetine 20 mg/day, after 50 weeks (total duration) of fluoxetine 20 mg/day, the fluoxetine treated patients had a statistically significantly lower rate of re-emergence of depressive symptoms than those on placebo.
text: The average DRSP total score decreased by 38% on fluoxetine 20 mg/day, 35% on fluoxetine 10 mg/day and 30% on placebo.
text: The average DRSP social and functional impairment symptom cluster score decreased 42% on fluoxetine 20 mg/day, 40% on fluoxetine 10 mg/day and 33% on placebo.
text: Fluoxetine 20 mg and 60 mg per day were also significantly more effective than placebo on a number of secondary measures of mood, physical symptoms and social impairment.